Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Mauro, Pia M.Philbin, Morgan M.
Greene, Emily R.
Diaz, José E.
Askari, Melanie S.
Martins, Silvia S.
Keyword
Cannabis useCannabis use disorder
Daily cannabis use
Health disparity
Medical cannabis laws
Medical cannabis use
Policy
Race and ethnicity
Sexual identity
Journal title
Preventive Medicine ReportsDate Published
2022-08Publication Volume
28Publication Begin page
101822
Metadata
Show full item recordAbstract
Differences in cannabis use patterns among racial, ethnic and sexual minoritized identity subgroups have been attributed to marginalized identity stressors. However, associations at the intersection of these minoritized identities remain underexplored in a changing medical cannabis law (MCL) context. We estimated medical cannabis and daily cannabis use, and cannabis use disorder (CUD) by intersecting racial, ethnic and sexual minoritized identity subgroups. We included 189,800 adults in the 2015-2019 National Survey on Drug Use and Health identifying as non-Hispanic white, non-Hispanic Black, or Hispanic and self-reported heterosexual, gay/lesbian, or bisexual sexual identity. We estimated the adjusted odds of past-year: (a) any medical cannabis, (b) daily cannabis use (i.e., 300 + days/year), and (c) DSM-5-proxy CUD by sexual identity, stratified by race and ethnicity. Cannabis measures were higher among sexual minoritized groups than heterosexual adults across racial and ethnic subgroups. Bisexual adults had higher odds of any medical cannabis use than their heterosexual counterparts: non-Hispanic white (6.4% vs. 1.8%; aOR = 2.6, 95% CI = [2.5-3.5]), non-Hispanic Black (4.1% vs. 1.7%; aOR = 2.7, 95% CI = [1.6-4.5]), and Hispanic adults (5.3% vs. 1.8 %; aOR = 2.6, 95% CI = [1.9-3.3]). We found heterogeneous associations with state MCL status across subgroups stratified by race and ethnicity. Bisexual adults in MCL states had higher odds of any medical cannabis use among non-Hispanic white (aOR = 2.0, 95% CI = [1.4-2.9]) and Hispanic (aOR = 3.6, 95% CI = [1.2-10.2]) adults compared to their non-MCL counterparts, but this was marginal among non-Hispanic Black bisexual adults (aOR = 1.6, 95% CI = [1.0-2.6]). Studies should assess intended and unintended cannabis policy effects among racial, ethnic, and sexual identity subgroups.Citation
Mauro PM, Philbin MM, Greene ER, Diaz JE, Askari MS, Martins SS. Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context. Prev Med Rep. 2022 May 13;28:101822. doi: 10.1016/j.pmedr.2022.101822. PMID: 35620050; PMCID: PMC9127402.DOI
10.1016/j.pmedr.2022.101822ae974a485f413a2113503eed53cd6c53
10.1016/j.pmedr.2022.101822
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws.
- Authors: Martins SS, Segura LE, Levy NS, Mauro PM, Mauro CM, Philbin MM, Hasin DS
- Issue date: 2021 Sep 1
- Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups.
- Authors: Rypka KJ, Wendland ZD, Steele MV, Wehner MR, Yeung H, Mansh MD
- Issue date: 2024 Sep 1
- Medical and Non-Medical Opioid Use at the Intersection of Gender and Sexual Identity: Associations with State Medical Cannabis Law Status in a U.S. National Sample of Adults.
- Authors: Mauro PM, Philbin MM, Greene ER, Askari MS, Martins SS
- Issue date: 2021 Nov
- Differences in Cardiovascular Health at the Intersection of Race, Ethnicity, and Sexual Identity.
- Authors: Rosendale N, Wood AJ, Leung CW, Kim AS, Caceres BA
- Issue date: 2024 May 1
- Elevated risk of substance use disorder and suicidal ideation among Black and Hispanic lesbian, gay, and bisexual adults.
- Authors: Kelly LM, Shepherd BF, Becker SJ
- Issue date: 2021 Sep 1
Related items
Showing items related by title, author, creator and subject.
-
Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement.Johnson, Emma C; Tillman, Rebecca; Aliev, Fazil; Meyers, Jacquelyn L; Salvatore, Jessica E; Anokhin, Andrey P; Dick, Danielle M; Edenberg, Howard J; Kramer, John R; Kuperman, Samuel; et al. (2019-01-01)Background and aims: Few studies have explored how polygenic propensity to cannabis use unfolds across development, and no studies have yet examined this question in the context of environmental contributions such as peer cannabis use. Outlining the factors that contribute to progression from cannabis initiation to problem use over time may ultimately provide insights into mechanisms for targeted interventions. We sought to examine the relationships between polygenic liability for cannabis use, cannabis use trajectories from ages 12-30 years and perceived peer cannabis use at ages 12-17 years. Design: Mixed-effect logistic and linear regressions were used to examine associations between polygenic risk scores, cannabis use trajectory membership and perceived peer cannabis use. Setting: United States. Participants: From the Collaborative Study on the Genetics of Alcoholism (COGA) study, a cohort of 1167 individuals aged 12-26 years at their baseline (i.e. first) interview. Measurements: Key measurements included life-time cannabis use (yes/no), frequency of past 12-month cannabis use, maximum life-time frequency of cannabis use, cannabis use disorder (using DSM-5 criteria) and perceived peer cannabis use. Polygenic risk scores (PRS) were created using summary statistics from a large (n = 162 082) genome-wide association study (GWAS) of cannabis use. Findings: Three trajectories reflecting no/low (n = 844), moderate (n = 137) and high (n = 186) use were identified. PRS were significantly associated with trajectory membership [P = 0.002-0.006, maximum conditional R2 = 1.4%, odds ratios (ORs) = 1.40-1.49]. Individuals who reported that most/all of their best friends used cannabis had significantly higher PRS than those who reported that none of their friends were users [OR = 1.35, 95% confidence interval (CI) = 1.04, 1.75, P = 0.023]. Perceived peer use itself explained up to 11.3% of the variance in trajectory class membership (OR = 1.50-4.65). When peer cannabis use and the cannabis use PRS were entered into the model simultaneously, both the PRS and peer use continued to be significantly associated with class membership (P < 0.01). Conclusions: Genetic propensity to cannabis use derived from heterogeneous samples appears to correlate with longitudinal increases in cannabis use frequency in young adults.
-
Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users.Johnson, Emma C; Colbert, Sarah M C; Jeffries, Paul W; Tillman, Rebecca; Bigdeli, Tim B; Karcher, Nicole R; Chan, Grace; Kuperman, Samuel; Meyers, Jacquelyn L; Nurnberger, John I; et al. (2022-12-21)Risk for cannabis use and schizophrenia is influenced in part by genetic factors, and there is evidence that genetic risk for schizophrenia is associated with subclinical psychotic-like experiences (PLEs). Few studies to date have examined whether genetic risk for schizophrenia is associated with cannabis-related PLEs.
-
The Impact of Cannabis on Mental Health Disorders: A Literature ReviewHunt, Cecelia (SUNY Brockport, Honors College, 2022-04)The topic of cannabis has been a taboo subject since the War on Drugs began decades ago. The use of cannabis in the medical setting has become more and more prominent, as it has been found to have multiple helpful properties. Cannabis is also known as marijuana and these two terms may be used interchangeably throughout this paper. There are two components in cannabis that may be mentioned throughout this literature review. Delta-9-tetrahydrocannabinol (THC) is considered the psychoactive component, while Cannobidiol (CBD) is nonpsychoactive. Psychoactive substances are things that affect brain function and cause changes in mood, thoughts, and behaviors (National Institute, n.d). Although the research is limited, marijuana has been found to help people who are diagnosed with epilepsy, as well as people who suffer from chronic pain (Safakish et al., 2020).